Role of HIV drug resistance testing in antiretroviral drug development
29 March 2005. Related: On the web.
FDA is announcing the availability of a draft guidance for industry entitled “Role of HIV Drug Resistance Testing in Antiretroviral Drug Development.” This draft guidance addresses the role of HIV resistance testing during antiretroviral drug development and postmarketing.
The draft guidance represents the agency’s current thinking on the role of HIV resistance testing in antiretroviral drug development – draft guidance.